Managing Negative Symptoms of Schizophrenia

Erscheinungsjahr 2020
ISBN: 978-0-19-884012-1
Verlag: Oxford University Press

Buch, Englisch, 144 Seiten, Format (B × H): 137 mm x 213 mm, Gewicht: 204 g

Reihe: Oxford Psychiatry Library

Schizophrenia is one of the most severe psychiatric disorders, carrying with it significant stigma and a number of debilitating symptoms. While material on its "positive" symptoms, such as hallucinations and delusions, is readily available, its "negative" symptoms, which present heterogeneously as deficits across a variety of domains, are not nearly so well-documented and often go undiagnosed with no effective treatment. Given the poor functioning and outcomes which
occur as a result of these symptoms, it is imperative they receive greater focus.

Part of the Oxford Psychiatry Library (OPL) series, this concise pocketbook provides readers with a comprehensive overview of the definition, evaluation, and treatment of negative symptoms. Written by experts in the field, with key points at the beginning of each chapter for quick reference, this is an invaluable resource for any mental health care professional working with individuals affected by schizophrenia.

Autoren/Hrsg.

Bitter, István

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie

Über Autor(innen)

István Bitter, MD., PhD., DSc. is Professor of the Department of Psychiatry and Psychotherapy at Semmelweis University in Budapest, Hungary. A graduate of Semmelweis University, he is board-certified as a Specialist in Neurology, Psychiatry, Psychotherapy, and Clinical Pharmacology. He worked in Austria and Germany, and was visiting professor at the New York University Department of Psychiatry and research scientist at N.S. Kline Institute for Psychiatric
Research in the USA. His current research focuses on schizophrenia, ADHD, clinical psychopharmacology, and epidemiology, including the use of "real world data". Dr. Bitter is a founding member of the European Group for Research in Schizophrenia, co-chair of the ECNP Network for Schizophrenia, chair of the EPA
Section of Psychopharmacology, and a member of the Executive Board of the National Brain Research Program in Hungary.